Strata Critical Medical, Inc.

For the period ended Dec 31, 2025. Filed Mar 3, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 3, 2026

SRTA$6.05+8.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets F-

(in thousands, except share and per share data)

	December 31,2025	December 31,2024
Assets
Current assets:
Cash and cash equivalents	$30,968	$16,072
Restricted cash	264	263
Accounts receivable, net of allowance of $1,066 and $— at December 31, 2025 and December 31, 2024, respectively	39,958	19,822
Short-term investments	30,263	108,757
Prepaid expenses and other current assets	24,739	4,676
Current assets of discontinued operations	—	11,152
Total current assets	126,192	160,742
Non-current assets:
Property and equipment, net	36,444	28,465
Intangible assets, net	47,502	7,964
Goodwill	88,210	15,540
Operating right-of-use asset	3,107	2,831
Other non-current assets	24,017	118
Non current assets of discontinued operations	—	41,015
Total assets	$325,472	$256,675
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable and accrued expenses	$19,142	$9,220
Operating lease liability, current	652	682
Current liabilities of discontinued operations	—	12,824
Total current liabilities	19,794	22,726
Non-current liabilities:
Warrant liability	1,530	5,808
Operating lease liability, long-term	2,655	2,336
Deferred tax liability	348	—
Other non-current liabilities	22,073	—
Non-current liabilities of discontinued operations	—	3,867
Total liabilities	46,400	34,737
Commitments and Contingencies (Note 14)
Stockholders' Equity
Preferred stock, $0.0001 par value, 2,000,000 shares authorized; no shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively	—	—
Common stock, $0.0001 par value; 400,000,000 authorized; 86,702,183 and 79,419,028 shares issued at December 31, 2025 and December 31, 2024, respectively	7	7
Additional paid in capital	424,616	407,076
Accumulated other comprehensive income	—	1,753
Accumulated deficit	(145,551)	(186,898)
Total stockholders' equity	279,072	221,938
Total liabilities and stockholders' equity	$325,472	$256,675

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.